Labshake search
Citations for Tocris :
51 - 100 of 661 citations for Ephrin type A receptor 2 EphA2 Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... CNQX (10 μM, Tocris; an AMPA receptor antagonist), glycine (10 μM ...
-
bioRxiv - Neuroscience 2024Quote: Oxytocin receptor antagonist (OTRA; L-368,899; Tocris 2641) was dissolved in saline 95% and DMSO 5% ...
-
bioRxiv - Physiology 2021Quote: ... Picrotoxin (100 µM) was used to block GABAA-receptor-mediated currents and D-2-amino-5-phosphonovalerate (APV; 20 µMm, Tocris Bioscience), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2021Quote: ... To interfere with group I metabotropic glutamate receptor (mGluR) signaling we used bath application of either the mGlu1 receptor antagonist YM298198 (1 μM, Tocris, Germany) or the mGluR5 receptor antagonist MPEP (10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... the NMDA receptor blocker D-AP5 (25 μM; Tocris), and the GABAA receptor blocker picrotoxin (50 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... and the GABAA receptor blocker picrotoxin (50 μM; Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK ...
-
bioRxiv - Neuroscience 2019Quote: ... the AMPA/kainate receptor antagonist 50μM NBQX (Tocris Bioscience) (Chandler et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 µM SR95531 (a blocker for GABAA receptors; Tocris) was used to verify the GABAergic nature of the currents recorded (data not shown) ...
-
bioRxiv - Neuroscience 2021Quote: ... the TrkB receptor antagonist ANA-12 (10 µM, Tocris), PKA inhibitor H89 (10 µM ...
-
Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal GraybioRxiv - Neuroscience 2022Quote: ... 5HT2C receptor antagonist RS102221 (5 µM, Tocris, Minneapolis, MN) was added in the bath ...
-
bioRxiv - Neuroscience 2019Quote: ... quinpirole for D2-like receptors (10–50 µM; Tocris); and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM ...
-
bioRxiv - Neuroscience 2022Quote: ... AP5 + CNQX cocktail (NMDA and AMPA receptor antagonists; Tocris) or aCSF as vehicle control ...
-
bioRxiv - Neuroscience 2022Quote: ... adrenergic α1A receptor antagonist – RS17053 (40 μM, Tocris 0985); adrenergic α1B receptor antagonist – Chloroethylclonidine (30 μM ...
-
bioRxiv - Neuroscience 2022Quote: ... muscarinic acetylcholine receptor antagonist tiotropium bromide was from Tocris; 5-HT (100 μM ...
-
bioRxiv - Genomics 2023Quote: ... and the GABA-B receptor antagonist CGP55845 (Tocris #1246). Experiments with a series resistance of >15 MΩ or >20% change in series resistance were excluded from the final dataset ...
-
bioRxiv - Neuroscience 2023Quote: ... and NMDA receptor antagonist APV (50 μM, Tocris, 0106).
-
bioRxiv - Neuroscience 2023Quote: ... The GABAAR receptor agonist muscimol (10 μM, Tocris, 0289) was used to assess for functional GABAAR signaling ...
-
bioRxiv - Neuroscience 2023Quote: The GABAB-receptor antagonist CGP 54626 hydrochloride (Tocris Bioscience) was used at a concentration of 5 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... a third group of animals were treated as those in group 2 with the addition of CB1 receptor antagonist AM251 (1 µM) (Tocris Bioscience, Bristol, UK). After 8 DIV ...
-
bioRxiv - Neuroscience 2019Quote: ... Receptor antagonists used this study included: GYKI-53655 (AMPAR; Tocris), LY341495 (group II mGluR ...
-
bioRxiv - Neuroscience 2021Quote: ... or the mGluR5 receptor antagonist MPEP (10 μM, Tocris, Germany) alone ...
-
bioRxiv - Neuroscience 2019Quote: ... the selective D3 receptor antagonist SB 27701A (5 µM; Tocris); the selective D4 receptor antagonist L-745 ...
-
bioRxiv - Cell Biology 2021Quote: A non-brain penetrable Y1 receptor antagonist BIBO3304 (Tocris Bioscience) was prepared in Milli Q water at a concentration of 1 mg/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... Blocking GABAA receptors with SR 95531 hydrobromide (100 μM) (Tocris) led to over-excitability of the PN dendrites and irregular spontaneous spiking behavior ...
-
bioRxiv - Neuroscience 2022Quote: ... or the GABAB receptor blocker CGP-35348 (60 µM; Tocris). Neurons were visualized on an upright Olympus microscope (BX50WI or BX51WI ...
-
bioRxiv - Neuroscience 2023Quote: The MCH receptor antagonist SNAP-94847 hydrochloride (Tocris Bioscience, 3347) was administered IP at a dose of 20 mg/kg ...
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Neuroscience 2021Quote: ... GABA-α5 receptor inverse agonist L-655-708 (20 μM, Tocris) was bath applied in current-clamp recording to selectively block those receptor subtypes and measure effects on neuron firing properties (Drexler et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... we used a metabotropic glutamate receptor agonist (L-AP4, Tocris Bioscience) to block synaptic transmission between the photoreceptors and the ON-bipolar cells ...
-
bioRxiv - Neuroscience 2019Quote: ... and CGP 52432 (selective GABAB receptor antagonist) were obtained from Tocris Bioscience (Ellisville ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 hydrobromide (Gabazine, GABAA receptor antagonist, 10 μM, Tocris Bioscience, UK) were used to block inhibitory synaptic transmission ...
-
bioRxiv - Neuroscience 2022Quote: ... the non-selective dopamine receptor antagonist Flupenthixol (15μg/.5μl/side; Tocris) or sterile saline (.5μL/side) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 500 nM of the TGFβ receptor inhibitor A83-01 (Tocris, #2939), 1x B27 supplement (ThermoFisher ...
-
bioRxiv - Neuroscience 2022Quote: ... and adrenergic α1D receptors antagonist – BMY 7378 (10 μM, Tocris 1006).
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the NMDA receptor open-channel blocker MK-801 (Tocris, 1 mM) in the recording pipette solution ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2020Quote: ... followed by application of bicuculline (50 µM, a GABAA receptor antagonist, Tocris) for 1 min to inhibit inhibitory synaptic inputs and activate synaptic glutamate receptors ...
-
bioRxiv - Neuroscience 2023Quote: ... The selective 5-HT2C receptor antagonist RS102221 (Tocris Bioscience, #1050, Minneapolis, MN) was dissolved in a 50% aCSF and 50% sterile saline solution and infused bilaterally into the aBNST at a dose of 0.5 µg per side [14][14] ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Neuroscience 2023Quote: ... the selective D3 receptor agonist PD 128907 (PD; Tocris Bioscience, Bristol, UK) and antagonist SB 277011A (SB ...
-
bioRxiv - Neuroscience 2021Quote: ... and TCS-OX2-29 (TCS; OX2 receptor antagonist; 10 µM Tocris, Bristol, UK) were stored as 100 × concentrates at –20 ° C ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This cocktail prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... or the D1 receptor antagonist SCH 23390 hydrochloride (Tocris Bioscience, cat no: 0925) at a dose of 0.01 or 0.2 mg/kg ...
-
bioRxiv - Neuroscience 2019Quote: ... and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM; Tocris). For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM ...
-
bioRxiv - Physiology 2020Quote: ... injected with the dopamine receptor D2 (DRD2) agonist cabergoline (0.5 mg/kg, Tocris) or saline at 11:00 am ...
-
bioRxiv - Neuroscience 2021Quote: ... and glutamate receptors (NBQX, 10 μM, Tocris; and DL-AP5, 30 μM, Sigma).
-
bioRxiv - Neuroscience 2023Quote: ... The DREADD receptor was activated by intraperitoneal injection of clozapine (0.005mg/kg; Tocris) 5-10 minutes prior to the start of the experiment47,48 ...